Alternative Residential Management Services, Llp Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 322 Fm 3023 S, Goldthwaite, TX 76844 Phone: 325-648-3131 Fax: 325-648-3931 |
News Archive
A new SARS-CoV-2 vaccine candidate, developed by giving a key protein's gene a ride into the body while encased in a measles vaccine, has been shown to produce a strong immune response and prevent SARS-CoV-2 infection and lung disease in multiple animal studies.
ReVision Optics, a leading company in the research, development and manufacture of custom optical products to correct and maintain vision, announced today that it has begun its US clinical trial of the PresbyLens® corneal inlay. The clinical trial will evaluate the PresbyLens® corneal inlay for the correction of presbyopia, the age-related loss of near vision. The study began on April 6th with the treatment of three subjects by clinical investigator Dr. Stephen Slade of the Slade & Baker Vision Center in Houston, Texas.
Moody's Investors Service said its outlook for not-for-profit hospitals remains negative as weak revenue growth continues. The ratings agency called revenue projections for the coming 18 months "modest" in a newly released report and described sluggish revenue growth as the "single most significant challenge hospitals currently face."
The U.S. Food and Drug Administration today announced a partnership agreement with the University of Rochester to form the Analgesic Clinical Trial Innovations, Opportunities, and Networks (ACTION) Initiative.
In a pilot study by Case Western Reserve University's Frances Payne Bolton School of Nursing, 20 grandmothers were able to lower their stress levels with a biofeedback device that tracks breathing patterns.
› Verified 6 days ago